News for 'drug regulations'

Glenmark gets US FDA nod to sell painkiller drug

Glenmark gets US FDA nod to sell painkiller drug

Rediff.com6 Dec 2010

Glenmark said it along with its US-based partner has got the US health regulator's nod to manufacture and market two oxycodone products, used for treating moderate to severe pain, in the American market. The company's US arm, Glenmark Generics Inc and Lehigh Valley Technologies (LVT) have received US Food and Drug Administration nod for Oxycodone immediate release capsules, the company said in a filing to the Bombay Stock Exchange.

Dr Reddy's A-team moves on putting house in order

Dr Reddy's A-team moves on putting house in order

Rediff.com10 Oct 2018

After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set out to bring the house in order.

Twenty-five essential drugs to see 90% decline in prices

Twenty-five essential drugs to see 90% decline in prices

Rediff.com6 Jul 2013

The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

Rediff.com11 Sep 2020

The DCGI also directed Serum Institute of India to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report.

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Drugs ban: Partial relief for Wockhardt, Glaxo & Griffon

Rediff.com18 Mar 2016

The Delhi High Court on Friday stayed the ban on some fixed dose combination (FDC) drugs of Glaxo SmithKline, Wockhardt and Laboratories Griffon but said action against their sale could be taken in the absence of valid sale and marketing licence.

Sharapova's intent questioned - Why was she taking banned heart drug?

Sharapova's intent questioned - Why was she taking banned heart drug?

Rediff.com9 Mar 2016

'Sharapova has been a US resident since early in her career, which does bring in a question of how or why she is using a drug that is not licensed there'

WHO meet next week to discuss Covaxin approval

WHO meet next week to discuss Covaxin approval

Rediff.com18 Oct 2021

The World Health Organisation's technical advisory group will meet on October 26 to consider the Emergency Use Listing (EUL) of Covaxin, a vaccine developed by Hyderabad-based Bharat Biotech protecting against COVID-19, the global health agency's chief scientist said.

Less competition, demand-supply gap push US drug prices

Less competition, demand-supply gap push US drug prices

Rediff.com13 Oct 2014

Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.

Will Monsoon Session Be Another Washout?

Will Monsoon Session Be Another Washout?

Rediff.com27 Jul 2023

The productivity of the Budget session was abysmal. The Lok Sabha functioned for 33% of its scheduled time (46 hours); the Rajya Sabha 24% (32 hours).

Ranbaxy may lose $140 mn on US ban

Ranbaxy may lose $140 mn on US ban

Rediff.com23 Sep 2008

Ranbaxy Laboratories, India's biggest drugmaker, may lose as much as $140 million of revenue in 2009 after the US drug regulator blocked sale of more than 30 generic medicines and 7 APIs made in two factories of the company, according to analysts.

DCGI finds no link between Covid vaccine shot and 'adverse' reaction

DCGI finds no link between Covid vaccine shot and 'adverse' reaction

Rediff.com2 Dec 2020

The DCGI arrived at the conclusion on Wednesday based on the recommendations of an independent expert committee which has also opined that compensation should not be paid to the volunteer, they said.

Ranbaxy drugs cleared FDA test before import alert

Ranbaxy drugs cleared FDA test before import alert

Rediff.com11 Jun 2013

FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.

Indian drug cos to benefit as US expedites generic clearances

Indian drug cos to benefit as US expedites generic clearances

Rediff.com12 May 2014

Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.

Covid vaccine to cost Rs 290 to govt; Rs 585 in pvt mkt: Serum

Covid vaccine to cost Rs 290 to govt; Rs 585 in pvt mkt: Serum

Rediff.com4 Jan 2021

Serum Institute of India, the world's largest vaccine manufacturer, has a licence to produce the shot and has already manufactured close to 50 million doses.

Does India's food regulator remind us of the 'inspector raj'?

Does India's food regulator remind us of the 'inspector raj'?

Rediff.com7 Sep 2015

Regulator's nod assumed more importance after the Maggi issue.

Why substandard and fake drugs are rampant in India

Why substandard and fake drugs are rampant in India

Rediff.com14 Jun 2013

Substandard and fake drugs are rampant in India because of the highly fragmented industry.

Drug prices to stay within limits

Drug prices to stay within limits

Rediff.com7 Jan 2008

The price regulatory pharma body has set limits to the extent pharma companies can increase the price of medicines in a year.

Why Nestle is willing to engage with food regulator constructively

Why Nestle is willing to engage with food regulator constructively

Rediff.com14 Sep 2015

The high court had given the company six weeks for retesting.

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Rediff.com25 Jun 2020

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With More drugmakers in line to launch the drug soon, the prices may see a further erosion.

Laws that regulate black money in India

Laws that regulate black money in India

Rediff.com10 Nov 2014

If any foreign account holder violates Indian laws, tax authorities can enforce repatriation of funds.

Novartis sues Biocon for patent breach

Novartis sues Biocon for patent breach

Rediff.com4 Apr 2014

The multinational has filed infringement proceedings and is seeking an injunction against the Indian rival at the Delhi High Court, trying to block the Bangalore-based biotechnology firm from launching a generic version of Galvus, also known as vildagliptin.

NPPA slaps Rs 300-crore penalty on Novartis

NPPA slaps Rs 300-crore penalty on Novartis

Rediff.com13 Oct 2014

Drug major Novartis has been slapped with a Rs 300-crore penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine.

Scanner on Novartis for giving 'fake' documents

Scanner on Novartis for giving 'fake' documents

Rediff.com10 Feb 2014

Swiss drug maker Novartis might face tough action from the country's drug regulator for allegedly giving fake documents while seeking renewal of registration for Tiamulin Hydrogen Fumerate (80 per cent granules), sources said.

Ranbaxy recalls 29,790 packs of anti-allergy drug in US

Ranbaxy recalls 29,790 packs of anti-allergy drug in US

Rediff.com2 May 2014

Ranbaxy Laboratories is recalling 29,790 blister packs of anti-allergy drug in the US, manufactured by its arm Ohms Laboratories, due to defective packaging.

Drug makers told to give pricing details in 10 days

Drug makers told to give pricing details in 10 days

Rediff.com6 Jun 2014

The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.

US regulators recommend pause on J&J vaccine over rare blood clots

US regulators recommend pause on J&J vaccine over rare blood clots

Rediff.com13 Apr 2021

In a joint statement, the CDC and the FDA said they were investigating clots in six women in the days after vaccination, in combination with reduced platelet count.

Be ready to receive first supply of COVID-19 vaccine: Govt to states

Be ready to receive first supply of COVID-19 vaccine: Govt to states

Rediff.com7 Jan 2021

The further distribution of vaccine to the districts will be done as per the registered beneficiaries, for which a separate communication will be done shortly, the letter stated.

Sensex rallies 308 points to end at lifetime high

Sensex rallies 308 points to end at lifetime high

Rediff.com4 Jan 2021

TCS was the top gainer in the Sensex pack, rising around 2 per cent, followed by ONGC, SBI, L&T, Infosys, HCL Tech, ICICI Bank and Axis Bank. The broader NSE Nifty surged hit a record high of 14,109.40.

No sabotage at Toansa plant, says Ranbaxy

No sabotage at Toansa plant, says Ranbaxy

Rediff.com12 Feb 2014

Company is among the few companies in the sector getting pulled up by FDA for violations at its factories in India.

India gets 3rd vaccine as DCGI approves Sputnik V

India gets 3rd vaccine as DCGI approves Sputnik V

Rediff.com13 Apr 2021

According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.

ATC tests positive for psychoactive substance, removed from duty

ATC tests positive for psychoactive substance, removed from duty

Rediff.com21 Aug 2022

The sources said that an ATC posted at the Indira Gandhi International Airport in New Delhi was subjected to the drug test.

India defends right to issue drug 'compulsory licences'

India defends right to issue drug 'compulsory licences'

Rediff.com23 Mar 2016

The USTR has placed India on its "priority watch" list for two years in a row, saying the country's patent laws unfairly favour local drug makers.

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

US FDA likely to inspect new Visakhapatnam arm of Divi's Labs in Jan

Rediff.com31 Dec 2013

The move assumes significance because a go-ahead from the US Food and Drug Administration for the new unit in Visakhapatnam is likely to give a huge boost to the company's revenues in upcoming quarters.

UP bans sale of halal-certified products, no restriction on exports

UP bans sale of halal-certified products, no restriction on exports

Rediff.com19 Nov 2023

In a statement, the state government alleged 'malicious attempts' to discourage the use of products lacking a halal certificate not only seek 'unfair financial benefits' but also form part of a 'pre-planned strategy to sow class hatred, create divisions in society, and weaken the country' by "anti-national elements".

WHO clears Serum Institute's Covovax for emergency use

WHO clears Serum Institute's Covovax for emergency use

Rediff.com18 Dec 2021

'WHO issued an emergency use listing for Covovax, expanding the basket of WHO-validated vaccines against COVID-19. The vaccine is produced by the Serum Institute of India under licence from Novavax,' the world health body said in a tweet on Friday.

US regulator not happy with Sun Pharma's reply on import alert

US regulator not happy with Sun Pharma's reply on import alert

Rediff.com21 May 2014

In March, the FDA had issued an import alert, banning formulations and active pharmaceutical ingredients from the factory.

Drug patent settlements to come under EU scanner

Drug patent settlements to come under EU scanner

Rediff.com13 Jan 2010

In a statement on Tuesday, the European Commission said it had requested 'information from certain pharma companies asking them to submit copies of their patent settlement pacts.'

Modi first foreign head to get Bhutan's highest civilian honour

Modi first foreign head to get Bhutan's highest civilian honour

Rediff.com22 Mar 2024

Prime Minister Narendra Modi on Friday received Bhutan's highest civilian award, the 'Order of the Druk Gyalpo', making him the first foreign Head of the Government to receive the honour.